John K Leighton

Application of Emerging Technologies in Toxicology and Safety Assessment: Regulatory Perspectives

John K Leighton, J. Leighton, 2005, International journal of toxicology.

Tasigna for Chronic and Accelerated Phase Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia Resistant to or Intolerant of Imatinib

Richard Pazdur, Robert Justice, Christine Garnett, 2008, Clinical Cancer Research.

Pharmacogenomic data submissions to the FDA: non-clinical case studies.

John K Leighton, Donna Mendrick, David Jacobson-Kram, 2004, Pharmacogenomics.